Freestyle Libre Flash Glucose Monitoring System
Abbott Diabetes Care, Inc. · Decision date Sep 1, 2026
What did the FDA decide?
P160030/S058 is a 30-day notice recorded with decision OK30 on 2026-09-01 for the FreeStyle Libre Flash Glucose Monitoring System. The reported change is the addition of a secondary supplier and manufacturer for subcomponents and subassemblies for sensor kits. The sensor is a component of the FreeStyle Libre 14-day and FreeStyle Libre Pro systems; the source gives no further detail on which subcomponents, which supplier, or which manufacturing steps are involved.
Because the identifier and supplement type establish it, this is a supplement to PMA P160030, not an original approval of the whole system, and it does not alter the parent approval. The field label categorizes the reason as a process change involving a manufacturer, sterilizer, packager or supplier. The stated purpose is administrative and manufacturing-related; it is not independent evidence of sensor safety or clinical effectiveness, and no new indication or clinical use should be inferred.
FDA approval order statement
addition of a secondary supplier and manufacturer for subcomponents and subassemblies for sensor kits. The sensor is a component of the FreeStyle Libre 14-day and FreeStyle Libre Pro Flash Glucose Monitoring Systems
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Clinical Chemistry
- Decision date
- Sep 1, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160030/S058
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott Diabetes Care, Inc.
- Product code
- PZE
- Decision code
- OK30
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated.
- Applicant
- Abbott Diabetes Care, Inc.
- Product code
- PZE
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160030. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160030 · Original PMA
Freestyle Libre Flash Glucose Monitoring System
P160030/S058 received
Application receipt date recorded by FDA.
P160030/S058 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P160030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott Diabetes Care, Inc. | PMA approval | Sep 27, 2017 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Diabetes Care, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1360 S. Loop Dr., Alameda, CA, 94502
Sources and methodology
- Original FDA record: P160030/S058
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records